Recursion Pharmaceuticals operates as a TechBio company, using its proprietary Recursion OS to automate biological experiments and analyze them with artificial intelligence. The company generates vast ...
Ben Taylor, CFO of Recursion, here with us. Thanks so much for joining us. Sure. Great. And first of all, thanks for having us here, Tommie. This is always a terrific conference and great to be here.
SACRAMENTO, Calif. — Gov. Gavin Newsom on Wednesday unveiled a revised 2026-27 California budget proposal that he said eliminates the state’s structural deficit through 2028 while preserving major ...
Recursive Superintelligence, founded by former Google, Meta and OpenAI researchers, is part of a growing effort to automate the creation of artificial intelligence. By Cade Metz Reporting from San ...
The war’s economic effects are hitting all sorts of fossil-derived products. As the war in Iran continues to engulf the Middle East and the Strait of Hormuz stays closed, one of the most visible ...
Shares of Recursion Pharmaceuticals (RXRX) spiked on Wednesday after the AI-driven drug developer significantly exceeded Street forecasts with its Q4 2025 financials, thanks primarily to a milestone ...
SALT LAKE CITY, Feb. 25, 2026 (GLOBE NEWSWIRE) -- Recursion (Nasdaq: RXRX) a leading clinical stage TechBio company decoding biology to radically improve lives, today reported business updates and ...
The United States of America (United States) and the Republic of North Macedonia (North Macedonia) have agreed to a Framework for an Agreement on Reciprocal, Fair, and Balanced Trade (Agreement) to ...
Spectacle guaranteed in these groups. This Friday afternoon will be the World Cup draw. Between tension, stress, and relief, it’s always a special moment to follow, as the future of many nations in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results